Dillon & Associates Inc Neogenomics Inc Transaction History

Dillon & Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$9.09 - $19.45 $72,720 - $155,600	8,000 New	8,000 $139,000
Q1 2022 May 06, 2022	SELL	$12.15 - $35.28 $97,200 - $282,240	-8,000 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$18.96 - $29.84 $151,680 - $238,720	8,000 New	8,000 $232,000

293

124M

698K

116K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.7B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Dillon & Associates Inc with notifications on news.